Stockscreener 앱 받기
2.515
5.81%
-0.155
Microbot Medical Inc 주식(MBOT)의 최신 뉴스
Will Microbot Medical Inc. (CY9D) stock outperform global peers2025 Momentum Check & Expert Verified Movement Alerts - newser.com
Will Microbot Medical Inc. (CY9D) stock gain from green policiesJuly 2025 Spike Watch & Long-Term Investment Growth Plans - newser.com
Using Ichimoku Cloud for Microbot Medical Inc. technicalsAnalyst Downgrade & Weekly Setup with ROI Potential - newser.com
Real time pattern detection on Microbot Medical Inc. stock2025 EndofYear Setup & AI Enhanced Execution Alerts - newser.com
Why Microbot Medical Inc. is moving today2025 Volatility Report & Daily Growth Stock Investment Tips - newser.com
Real time scanner hits for Microbot Medical Inc. explainedMarket Activity Recap & Real-Time Market Trend Scan - newser.com
Is Microbot Medical Inc. building a consolidation baseEarnings Overview Summary & Consistent Return Strategy Ideas - newser.com
Microbot Medical Inc.Common Stock (NQ: MBOT - FinancialContent
Visual trend scoring systems applied to Microbot Medical Inc.CEO Change & AI Enhanced Market Trend Forecasts - newser.com
What risks investors should watch in Microbot Medical Inc. stockDollar Strength & Reliable Breakout Forecasts - newser.com
Why Microbot Medical Inc. (CY9D) stock fits value portfoliosSwing Trade & Safe Swing Trade Setups - newser.com
Can Microbot Medical Inc. stock sustain revenue growth2025 Trading Volume Trends & Reliable Price Breakout Signals - nchmf.gov.vn
Microbot Medical Showcases LIBERTY® System Post-FDA Clearance - MSN
MBOT SEC FilingsMicrobot Med Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Microbot Medical Inc Debuts LIBERTY System at Oncology Symposium - TradingView
Microbot Medical (MBOT) to Showcase LIBERTY System at Key Oncolo - GuruFocus
Microbot Medical Inc. to Showcase LIBERTY® Endovascular Robotic System at First Post-FDA Clearance Medical Meeting - Quiver Quantitative
Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting - The Manila Times
Microbot Medical® to Commercially Debut the LIBERTY® System - GlobeNewswire
Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical ... - Bluefield Daily Telegraph
510(k) clearance: Microbot Medical debuts LIBERTY System at CIO, limited market release planned Q4 2025 - Stock Titan
What analysts say about Microbot Medical Inc stockEconomic Indicators Overview & Free Discover Breakout Stocks Early - earlytimes.in
MBOT plans first commercial exhibit of LIBERTY® post 510(k) in Miami - Stock Titan
H.C. Wainwright reiterates Buy rating on Microbot Medical stock at $12 - Investing.com Nigeria
H.C. Wainwright reiterates Buy rating on Microbot Medical stock at $12 By Investing.com - Investing.com Australia
HC Wainwright & Co. Reiterates Microbot Medical (MBOT) Buy Recommendation - Nasdaq
MBOT: HC Wainwright & Co. Reiterates Buy Rating with $12 PT | MB - GuruFocus
Microbot Medical partners with logistics firm for LIBERTY system launch By Investing.com - Investing.com Nigeria
Microbot Medical® Secures U.S. Based Logistics Partner to - GlobeNewswire
Microbot Medical (MBOT) Partners to Launch LIBERTY System - GuruFocus
Microbot Medical Partners for LIBERTY System Launch - TipRanks
Microbot Medical Inc Partners for LIBERTY® System Commercialization - TradingView
Microbot Medical partners with logistics firm for LIBERTY system launch - Investing.com
MBOT sets LIBERTY launch timeline with new U.S. 3PL partnership - Stock Titan
2.63%
0.86%
자본화:
|
볼륨(24시간):